Clinical management and outcomes of primary ovarian leiomyosarcoma - Experience from a sarcoma specialist unit

• Main Authors: Elena Cojocaru (Author), Githmi Palahepitiva Gamage (Author), John Butler (Author), Desmond P. Barton (Author), Khin Thway (Author), Cyril Fisher (Author), Christina Messiou (Author), Aisha B. Miah (Author), Shane Zaidi (Author), Spyridon Gennatas (Author), Charlotte Benson (Author), Paul Huang (Author), Robin L. Jones (Author)
• Format: Book
• Published: Elsevier, 2021-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Ovarian sarcomas account for 1% of all ovarian malignancies and amongst these, primary ovarian leiomyosarcoma is the rarest subtype. Primary ovarian leiomyosarcoma has a very poor prognosis, with less than 20% of patients being alive at 5 years. Only a few cases have been published in the literature...